News
This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...
ATH434 is designed to reduce α-synuclein aggregation and oxidative stress by binding to and redistributing excess loosely bound iron in the brain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results